14.76
Precedente Chiudi:
$14.99
Aprire:
$14.88
Volume 24 ore:
59,155
Relative Volume:
0.42
Capitalizzazione di mercato:
$402.99M
Reddito:
$56.44M
Utile/perdita netta:
$-32.60M
Rapporto P/E:
-11.98
EPS:
-1.2318
Flusso di cassa netto:
$-35.15M
1 W Prestazione:
-4.90%
1M Prestazione:
+7.50%
6M Prestazione:
+25.08%
1 anno Prestazione:
+8.53%
Carlsmed Inc Stock (CARL) Company Profile
Nome
Carlsmed Inc
Settore
Industria
Telefono
858-295-9290
Indirizzo
1800 ASTON AVENUE, CARLSBAD
Compare CARL vs VEEV, BTSG, TEM, TXG, HQY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CARL
Carlsmed Inc
|
14.76 | 409.27M | 56.44M | -32.60M | -35.15M | -1.2318 |
|
VEEV
Veeva Systems Inc
|
260.98 | 42.23B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
57.88 | 12.27B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
58.74 | 11.13B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
TXG
10 X Genomics Inc
|
66.38 | 8.77B | 638.78M | -22.66M | 122.18M | -0.1744 |
|
HQY
Healthequity Inc
|
94.55 | 7.66B | 1.34B | 230.70M | 440.96M | 2.6695 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-18 | Iniziato | BTIG Research | Buy |
| 2025-08-18 | Iniziato | BofA Securities | Buy |
| 2025-08-18 | Iniziato | Goldman | Buy |
| 2025-08-18 | Iniziato | Piper Sandler | Overweight |
| 2025-08-18 | Iniziato | Truist | Buy |
Carlsmed Inc Borsa (CARL) Ultime notizie
Carlsmed (CARL) awards COO 50,000 stock options - Stock Titan
Carlsmed (CARL) COO discloses 22,489-share stake - Stock Titan
Carlsmed, Inc.: Shareholders Board Members Managers and Company Profile | US14280C1053 - marketscreener.com
Carlsmed appoints Jeff Bertolini as new COO - TipRanks
Carlsmed, Inc. Announces Chief Operating Officer Appointment - The Manila Times
Carlsmed names Jeffrey Bertolini as Chief Operating Officer - TradingView
symbol__ Stock Quote Price and Forecast - CNN
BlackRock Inc. Purchases New Holdings in Carlsmed, Inc. $CARL - MarketBeat
Jupiter Topco LLC Acquires New Holdings in Carlsmed, Inc. $CARL - MarketBeat
Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet - qz.com
Parkman Healthcare Partners LLC Invests $6.20 Million in Carlsmed, Inc. $CARL - MarketBeat
Carlsmed, Inc. (NASDAQ:CARL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Wall Street Zen Upgrades Carlsmed (NASDAQ:CARL) to "Hold" - MarketBeat
Carlsmed (CARL) plans up to $250M in stock, debt and warrant sales - Stock Titan
Carlsmed (CARL) Holds Steady Near $13.72 as Tight Range Signals Potential MoveDefined Outcome ETF - vinanet.vn
Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform - TradingView
Transcript : Carlsmed, Inc. Presents at Bank of America SMID Cap Virtual Conference, Aug-12-2026 11 - marketscreener.com
CARL: Personalized AI spine surgery platform accelerates growth with new reimbursement and strong clinical data - TradingView
CARL Q2 2026 Earnings: Narrower-Than-Expected Loss but Shares Slip 2.55%Tax Rate Impact - vinanet.vn
Carlsmed, Inc. Common Stock (NASDAQ: CARL) Share Price, CARL Stock News, CARL Share Price & Updates - Kalkine
Truist raises Carlsmed stock price target on strong growth outlook By Investing.com - Investing.com South Africa
Carlsmed Buy Rating Reaffirmed as 2026 Outlook Raised and Adoption Grows; $17 Price Target Maintained - TipRanks
Carlsmed (CARL) Stock Revenue Surge Meets A Wider Loss Per Share - Sahm
Carlsmed Q2 2026 revenue up 57% to USD 18.9M - Medical Buyer
Truist raises Carlsmed stock price target on strong growth outlook - Investing.com Nigeria
CARLSMED INC Q2 NET INCOME USD -10.5 MILLION - Moomoo
Truist Adjusts Price Target on Carlsmed to $20 From $18, Maintains Buy Rating - marketscreener.com
Carlsmed, Inc. Stock 12‑Month Price Target Raised to $19.2, Implies 42% Upside - TradingView
Carlsmed Inc. (CARL) Advances 4.79% to $14.21: Personalized Spine Tech Gains TractionBuy Signal Reports - dars.gov.et
Carlsmed Inc (CARL) (Q2 2026) Earnings Call Highlights: Revenue Surges 57% to $18. ... - Yahoo Finance UK
Carlsmed Q2 Earnings Call Highlights - Yahoo Finance
Carlsmed, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Carlsmed, Inc. (CARL) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
CARLSMED, INC. Q2 2026: Revenue $18.94M, EPS $(0.39) — 10-Q Summary - TradingView
Carlsmed reports Q2 2026 revenue $18.9M, raises full-year guidance to $74–$78M - TradingView
Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance - The Manila Times
Carlsmed, Inc. Raises Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
Carlsmed, Inc. $CARL Stock Holdings Lifted by Janus Henderson Group PLC - MarketBeat
Carlsmed (CARL) Earnings Date and Reports 2026 $CARL - MarketBeat
Carlsmed (CARL) Gains Favorable CMS Reimbursement Policy Boostin - GuruFocus
Carlsmed, Inc. expected to post a loss of 41 cents a shareEarnings Preview - TradingView
Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures - The Manila Times
Carlsmed Inc. (CARL) Holds Near $12.59 as Support and Resistance Levels TightenSmart Money Flow Stocks - dars.gov.et
Will Carlsmed, Inc. (CARL) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
Carlsmed, Inc. To Participate in Upcoming Investor Conferences - The Manila Times
Carlsmed, Inc. (NASDAQ:CARL) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
CARL|Carlsmed Ord Shs|Price:10.800|Chg%:-0.200 - TradingKey
Carlsmed Inc. (CARL) Holds Above Support as Stock Declines ModestlyStraddle Setup - dars.gov.et
Carlsmed Ord Shs (CARL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Carlsmed Inc. (CARL) Q1 2026 Earnings: EPS Beat Provides Cautious Optimism Amid Ongoing Market Volatility - vinanet.vn
KCM Capital Inc Invests $1.81 Million in Carlsmed, Inc. $CARL - MarketBeat
Carlsmed Inc Azioni (CARL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):